CJC-1295 without DAC + Ipamorelin
Pilih Konsentrasi
SKU: CP10
Key Benefits
- Combined dose 1-2 times daily
Common Research Uses
- CJC-1295 without DAC + IPA | Research Peptide | Aether Bio
Dosage Guidelines
Disclaimer: The dosages listed are not recommendations. This is a general guideline based on information we have gathered from various sources. Please consult with qualified researchers and professionals before use.
CJC-1295 without DAC + IPA, growth hormone peptide, GH peptide, synergistic gh release, enhanced fat loss and muscle growth, improved recovery and sleep, research peptide, Aether Bio
Product Details
CJC-1295 (no DAC) + Ipamorelin combines a GHRH analogue (Modified GRF 1-29) with a selective GHSR-1a agonist into a single pre-mixed protocol. The two pathways converge at the somatotrope to produce additive pulsatile GH release.
Mechanism of Action. CJC-1295 engages the GHRH receptor while Ipamorelin activates GHSR-1a; the two signals are orthogonal and synergistic at the pituitary level.
Applications. GHRH+GHRP synergy research, comparative pulsatile-GH-release pharmacology, somatotropic-axis modeling.
Customer Reviews
No reviews yet
Be the first to share your experience
Questions about this product?
Our team can help with specs, bulk orders, or custom concentrations.